News & Insights

ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an AI-driven, digital trial platform tailored for the life science industry. The combined solution will create a market-leading, unified software and data ecosystem for the modernization of clinical research throughout the drug-product lifecycle and across therapeutic areas.

Biofourmis and Lee Health are preparing to launch Hospital at Home, a home based hospital care model and expand their remote patient monitoring (RPM) program to support patients across the continuum.

Merger Establishes a Category of One Company That Can Deliver In-Home Care From Pre-Surgery, to Acute, Post-Acute, and Chronic Care.

Biofourmis has introduced a new digital measure for assessing nocturnal scratching and sleep quality in atopic dermatitis (AD) patients. Using wearable sensors and machine-learning, this tool provides objective, continuous monitoring to support drug development and improve patient outcomes.